Osteogenex Inc is categorized under Commercial Medical Research in Kansas City, KS and active since 2006.
Osteogenex Inc was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6213400 by the NAICS.
If you are seeking more information, feel free to contact Debra Ellies, Chief Executive Officer at the company’s single location by writing to 2002 West 39th Avenue, Kansas City, Kansas KS 66103 or by phoning (913) 945-6763. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Osteogenex Inc |
| Contact Person: | Debra Ellies, Chief Executive Officer |
| Address: | 2002 West 39th Avenue, Kansas City, Kansas 66103 |
| Phone Number: | (913) 945-6763 |
| Website Address: | osteogenex.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6213400 |
| Share This Business: |
Osteogenex Inc was started in 2006 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6213400. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Debra Ellies, Chief Executive Officer for inquiries that concern Osteogenex Inc by calling the company number (913) 945-6763, as your correspondence is most welcome. Additionally, the physical location of the single location of Osteogenex Inc can be found at the coordinates 39.05741,-94.60868 as well as the street address 2002 West 39th Avenue in Kansas City, Kansas 66103.
For its online presence, you may visit Osteogenex Inc’s website at osteogenex.com and engage with its social media outlets through on Twitter and on Facebook.